indapamide has been researched along with Coronary Artery Disease in 3 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Macfarlane, TV | 1 |
Pigazzani, F | 1 |
Flynn, RWV | 1 |
MacDonald, TM | 1 |
Thomopoulos, C | 1 |
Parati, G | 1 |
Zanchetti, A | 1 |
Camici, PG | 1 |
3 reviews available for indapamide and Coronary Artery Disease
Article | Year |
---|---|
The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.
Topics: Bendroflumethiazide; Blood Pressure; Coronary Artery Disease; Diuretics; Humans; Hypertension; Indap | 2019 |
Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 2015 |
From microcirculation to cardiac event: protection with Preterax.
Topics: Antihypertensive Agents; Cardiotonic Agents; Coronary Artery Disease; Drug Combinations; Humans; Hyp | 2008 |